Bharat Immunologicals (India) Valuation Overview

BIBCL -- India Stock  

INR 16.15  0.15  0.94%

Bharat Immunologicals shows prevailing Real Value of 16.049999999999997 per share. The current price of the firm is 16.15. At this time the firm appears to be fairly valued. Macroaxis approximates value of Bharat Immunologicals from analyzing the firm fundamentals such as Operating Margin of (25.69)% and Return On Asset of (1.69)% as well as examining its technical indicators and Probability Of Bankruptcy. In general, we favor to go long with undervalued instruments and to trade away overvalued instruments since at some point assets prices and their ongoing real values will blend.
 Time Horizon     30 Days    Login   to change
Bharat Immunologicals Biologicals Corp Ltd is rated below average in beta category among related companies. It is rated below average in price to book category among related companies .

Current Market Valuation

Bharat Immunologicals Valuation Boundaries
Fairly Valued
August 17, 2018
16.15
Market Value
16.05
Real Value
Target Odds
  
20.40
Upside
Bharat Immunologicals is not very risky asset. Calculation of real value of Bharat Immunologicals is based on 1 month time horizon. Increasing Bharat Immunologicals time horizon generally increases accuracy of value calculation and significantly improves predictive power of the methodology used.
Check also Trending Equities. Please also try Price Transformation module to use price transformation models to analyze depth of different equity instruments across global markets.